GoHearing Ultra vs Otofonix Encore

The GoHearing Ultra is a budget-priced behind-the-ear OTC hearing aid that earns a B grade with a SoundScore of 3.1/5 in our lab testing. At $499, it sits in the most affordable price tier of the OTC market, though its overall sound performance ranks #58 of 65 devices in its category. In our testing, the Ultra shows a distinctive performance profile with significant strengths and weaknesses. Feedback handling is excellent at 5.0/5, scoring 0.46 points above the category average—users can expect stable operation without whistling during typical wear. Music streaming quality is also a genuine strength at 3.6/5, performing 1.68 points above average, making it notably better for phone audio than most OTC devices. However, speech clarity scores reveal meaningful limitations. Speech in quiet environments measured just 1.0/5, which is 1.79 points below the category average and low in absolute terms. Speech in noise similarly scored 1.0/5, falling 0.48 points below average. Own-voice comfort rated 1.9/5, also below the category norm. These results suggest the Ultra may struggle to deliver the speech audibility improvements that many users prioritize. The GoHearing Ultra may suit budget-conscious consumers who primarily want reliable streaming audio and feedback-free operation, and who have modest expectations for speech enhancement. However, several competitors in the same price range—including the Elehear Beyond and Apple AirPods Pro 2—deliver substantially stronger overall sound performance. Users prioritizing speech clarity should consider these alternatives despite similar pricing.

The Otofonix Encore is a budget-priced prescription hearing aid available for $295, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This behind-the-ear device ranks #37 of 39 in the Prescription Hearing Aid category, placing it in the bottom tier of its class. In our standardized testing, the Encore demonstrates one clear strength: excellent feedback handling at 4.7/5, which means users are unlikely to experience whistling or squealing during normal use. However, the device shows significant limitations in other areas. Speech intelligibility scores are low in both quiet (1.0/5) and noisy environments (1.0/5), falling 2.40 and 1.11 points below category averages respectively. Music streaming performance scored 0.0/5, indicating this device is not suitable for those who want to stream audio content. The Encore uses disposable batteries and comes in a traditional behind-the-ear style. Notably, our tuned fit testing showed a slight decrease in overall performance compared to the initial fit, with the normalized score dropping from 2.8/5 to 2.4/5. Own-voice comfort also declined substantially when moving to a more occluding coupling. At this price point, consumers may want to consider alternatives. The RxEars Rxi offers substantially better performance at a similar budget price point with a score of 4.07/5. The Otofonix Encore may appeal to buyers seeking a very low-cost entry into prescription hearing aids who prioritize feedback stability, but those needing reliable speech clarity or streaming capabilities should explore other options.